Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 10:00 ET | Source: Baylor Genetics

Baylor Genetics Applauds Medi-Cal's Decision to Cover Whole Genome Sequencing

HOUSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading clinical diagnostic laboratory at the forefront of genetic testing, today announced its support for Medi-Cal's (California’s...
November 03, 2025 09:01 ET | Source: Agios Pharmaceuticals, Inc.

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

Agios today announced that new data on mitapivat, an oral pyruvate kinase activator, will be featured in oral and poster presentations during ASH
October 23, 2025 16:30 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

DEER PARK, Ill., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing...
October 20, 2025 02:00 ET | Source: Pharming Group N.V.

Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio

Pharming announces 12 abstracts have been accepted for presentation at 2025 ACAAI Annual Scientific meeting being held in Orlando, Florida on November 6-10
October 15, 2025 10:00 ET | Source: Baylor Genetics

Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today showcased new research in RNA sequencing (RNA-seq) to uncover...
October 14, 2025 07:00 ET | Source: Purespring Therapeutics

Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference

Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference London – 14 October 2025 - Purespring Therapeutics, a precision nephrology company focused on transforming...
October 14, 2025 06:00 ET | Source: Soleo Health Holdings, Inc.

Soleo Health Introduces State-of-the-Art Pharmacy and Infusion Center in Washington, D.C., Area

FRISCO, Texas and HERNDON, Va., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Soleo Health, a national provider of complex specialty pharmacy services, announced today the opening of its new state-of-the-art...
October 09, 2025 10:01 ET | Source: Optime Care

Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)

Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)
October 09, 2025 05:00 ET | Source: Italfarmaco

Italfarmaco Appoints Francesco Di Marco as Chief Executive Officer

MILAN, Italy, October 09, 2025 – Italfarmaco S.p.A. today announced that Dr. Francesco Di Marco has been appointed as Chief Executive Officer (CEO), effective January 1, 2026. Dr. Di Marco brings over...
October 08, 2025 10:00 ET | Source: Baylor Genetics

Baylor Genetics to Showcase Clinical and Diagnostic Utility of Genome Sequencing and Multi-omics Across Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

HOUSTON, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in genome sequencing...